PRINCIOTTA CARIDDI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 572
EU - Europa 433
AS - Asia 55
OC - Oceania 5
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 1.070
Nazione #
US - Stati Uniti d'America 572
IT - Italia 246
SE - Svezia 49
IE - Irlanda 34
DE - Germania 29
UA - Ucraina 29
VN - Vietnam 27
CN - Cina 17
FR - Francia 11
GB - Regno Unito 10
BE - Belgio 8
FI - Finlandia 8
TR - Turchia 6
AU - Australia 5
HU - Ungheria 2
IN - India 2
LU - Lussemburgo 2
NG - Nigeria 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
JP - Giappone 1
KR - Corea 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.070
Città #
Milan 170
Chandler 115
Fairfield 65
Ashburn 38
Nyköping 36
Jacksonville 35
Dublin 34
Houston 32
Wilmington 30
Woodbridge 29
Ann Arbor 25
Princeton 24
Cambridge 19
Seattle 15
Como 14
Dong Ket 14
Helsinki 8
New York 8
Rome 8
Dearborn 7
San Diego 7
Frankfurt am Main 6
London 6
Brussels 5
Izmir 5
Ogden 4
Berlin 3
Cassano Magnago 3
Guangzhou 3
Ixelles-Elsene 3
Melbourne 3
Redmond 3
Brescia 2
Budapest 2
Edinburgh 2
Hebei 2
Hefei 2
Hyderabad 2
Kunming 2
Lagos 2
Leawood 2
Lisbon 2
Los Angeles 2
Paris 2
Redwood City 2
Ronchis 2
Varese 2
Atlanta 1
Beijing 1
Boardman 1
Bratislava 1
Canberra 1
Cesano Boscone 1
Chicago 1
Dhaka 1
Fuzhou 1
Gambettola 1
Harbin 1
Matsuyama 1
New Bedfont 1
Parma 1
San Francisco 1
San Mateo 1
Seoul 1
Shenyang 1
Sydney 1
Vicenza 1
Villeurbanne 1
Washington 1
Wenzhou 1
Zhengzhou 1
Totale 831
Nome #
Chronic headaches with medication overuse (MOH): non significant influence of preliminary controller withdrawal programs on the response to Onabotulinumtoxin A prophylaxis. 101
Pharmacologically controlled withdrawal from medication overuse in chronic migraine does non improve the therapeutic response to long-term onabotulinumtoxin type-a prophylaxis 97
Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study 95
Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies 92
Posterior reversible encephalopathy syndrome and COVID-19: A series of 6 cases from Lombardy, Italy 91
Early BoNT-A treatment after controlled withdrawal in Medication Overuse Headache: selection criteria for an optimal cost benefit ratio. 87
Lamotrigine induced Brugada-pattern in a patient with genetic epilepsy associated with a novel variant in SCN9A 84
Is there a link between pain chronification, and allodynia and vitamin D deficiency in headache? 75
Serum D-serine levels are altered in early phases of Alzheimer’s disease: towards a precocious biomarker 69
Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient 68
An Example of a Stroke Unit Reshaping in the Context of a Regional Hub and Spoke System in the COVID-19 Era 62
Selegiline reduces daytime sleepiness in patients with Parkinson's disease 59
Depressive symptoms in amnesic mild cognitive impairment: an FDG-PET/CT study 54
New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series 44
Alzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition 20
Totale 1.098
Categoria #
all - tutte 5.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 0 5
2019/202045 0 0 0 3 0 10 11 6 1 6 0 8
2020/2021274 4 7 3 9 28 53 14 42 25 15 31 43
2021/2022141 23 11 7 5 13 5 9 11 8 21 11 17
2022/2023298 28 29 27 35 19 55 3 43 37 9 11 2
2023/2024297 46 43 42 65 59 22 4 3 8 4 1 0
Totale 1.098